Revalesio is a clinical-stage pharmaceutical company with a vision to develop safer and more effective treatments for people with an acute ischemic stroke and other neurological conditions. Our pioneering science addresses fundamental disease mechanisms to improve recovery and reduce disability in stroke and slow disease progression in chronic neurological conditions, aiming to make meaningful improvements in the quality of life of individuals who currently have few therapeutic treatment options.